We are live on ! Find out more
SCM

Soleus Capital Management Portfolio holdings

AUM $2.47B
1-Year Est. Return 115.63%
This Fund
S&P 500
This Quarter Est. Return
-19.28%
1 Year Est. Return
+115.63%
3 Year Est. Return
+435.52%
5 Year Est. Return
+604.31%
10 Year Est. Return
–
AUM
$85.9M
AUM Growth
-$17.7M
Cap. Flow
+$10.3M
Cap. Flow %
11.97%
Top 10 Hldgs %
58.4%
Holding
67
New
17
Increased
15
Reduced
14
Closed
19

Top Buys

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$5.49M
2
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$4.89M
3
ZYXI
Zynex
ZYXI
+$3.73M
4
ATRS
Antares Pharma, Inc.
ATRS
+$2.94M
5
VCEL icon
Vericel Corp
VCEL
+$2.53M

Top Sells

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$6.91M
2
AGN
Allergan plc
AGN
+$2.62M
3
DERM
Dermira, Inc.
DERM
+$2.5M
4
HUM icon
Humana
HUM
+$2.13M
5
BPMC
Blueprint Medicines
BPMC
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 97.9%
2 Real Estate 1.33%
3 Communication Services 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPIX
1
DELISTED
ESSA Pharma
EPIX
$8.32M 9.68%
2,080,421
+446,052
+27% +$2.24M
GRFS
2
Grifois
GRFS
$5.16B
$7.79M 9.07%
387,035
-65,865
-15% -$1.48M
ISEE
3
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$5.53M 6.43%
1,607,153
+938,782
+140% +$5.49M
HARP
4
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$5.45M 6.35%
47,093
+34,773
+282% +$4.89M
IRMD icon
5
iRadimed
IRMD
$1.21B
$5.01M 5.83%
234,810
+94,058
+67% +$2.24M
ALXN
6
DELISTED
Alexion Pharmaceuticals
ALXN
$4.29M 4.99%
47,800
+16,500
+53% +$1.62M
ZYXI
7
DELISTED
Zynex
ZYXI
$3.86M 4.49%
+383,420
New +$3.73M
DXCM icon
8
DexCom
DXCM
$27.6B
$3.62M 4.21%
53,800
-16,600
-24% -$1.03M
VCEL icon
9
Vericel Corp
VCEL
$2.3B
$3.23M 3.76%
352,332
+168,652
+92% +$2.53M
ADVM
10
DELISTED
Adverum Biotechnologies
ADVM
$3.07M 3.57%
31,390
-2,890
-8% -$337K
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.75M 3.21%
13,507
+6,660
+97% +$2.12M
AGN
12
DELISTED
Allergan plc
AGN
$2.59M 3.01%
14,600
-13,900
-49% -$2.62M
SYRE icon
13
Spyre Therapeutics
SYRE
$8.87B
$2.5M 2.91%
21,460
+3,133
+17% +$533K
MSON
14
DELISTED
Misonix Inc
MSON
$2.25M 2.61%
238,333
+59,737
+33% +$906K
ZYME icon
15
Zymeworks
ZYME
$1.68B
$2.18M 2.54%
61,528
+38,828
+171% +$1.59M
ATRS
16
DELISTED
Antares Pharma, Inc.
ATRS
$2.04M 2.37%
+864,100
New +$2.94M
ABBV icon
17
AbbVie
ABBV
$458B
$2.02M 2.35%
+26,500
New +$2.26M
UNH icon
18
UnitedHealth
UNH
$382B
$1.97M 2.29%
+7,900
New +$2.17M
AXNX
19
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.6M 1.86%
+63,000
New +$1.87M
ITMR
20
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$1.35M 1.57%
+114,865
New +$1.57M
RFL icon
21
Rafael Holdings
RFL
$111M
$1.14M 1.33%
90,379
+51,923
+135% +$907K
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.08M 1.25%
257,141
-93,159
-27% -$401K
LRMR icon
23
Larimar Therapeutics
LRMR
$416M
$1.04M 1.21%
112,367
+45,370
+68% +$596K
BIIB icon
24
Biogen
BIIB
$29.9B
$949K 1.1%
3,000
-4,500
-60% -$1.37M
ESTA icon
25
Establishment Labs
ESTA
$2.72B
$914K 1.06%
63,254
-30,306
-32% -$669K
1
2 3

Similar funds

TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
JC
JB Capital Wethersfield, Connecticut $2.48B AUM 22.31% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
BW
BIP Wealth Atlanta, Georgia $2.46B AUM 14.38% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return

Soleus Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Soleus Capital Management held 67 positions worth $85.9M, down 17% from $104M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Soleus Capital Management deployed $10.3M of net new capital in Q1 2020, opening 17 new positions and adding to 15 existing holdings. Its largest new stake was Zynex: 383,420 shares worth $3.86M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 96% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was Allergan plc, an estimated $2.62M trimmed.

  • Soleus Capital Management's largest Q1 2020 buy was Zynex: 383,420 shares worth $3.86M.
  • Soleus Capital Management added most to IVERIC bio, Inc. Common Stock in Q1 2020, an estimated $5.49M increase.
  • Soleus Capital Management's biggest Q1 2020 reduction was Allergan plc, cutting an estimated $2.62M.
  • Soleus Capital Management fully exited Wright Medical Group Inc in Q1 2020, selling an estimated $6.91M.
  • Soleus Capital Management's ten largest holdings make up 58% of its $85.9M portfolio in Q1 2020.
  • Soleus Capital Management opened 17 new positions and closed 19 in Q1 2020.
  • Soleus Capital Management's portfolio value fell 17% quarter-over-quarter to $85.9M.

Based on Soleus Capital Management's 13F filing for Q1 2020, filed 15 May 2020.